141 related articles for article (PubMed ID: 6095653)
1. Comparison of alpha-1-antitrypsin and alpha-1-antichymotrypsin in hepatocellular carcinoma: an immunoperoxidase study.
Ordóñez NG; Manning JT
Am J Gastroenterol; 1984 Dec; 79(12):959-63. PubMed ID: 6095653
[TBL] [Abstract][Full Text] [Related]
2. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
Rubel LR; Ishak KG; Benjamin SB; Knuff TE
Arch Pathol Lab Med; 1982 Dec; 106(13):678-81. PubMed ID: 6291490
[TBL] [Abstract][Full Text] [Related]
3. Expression of laminin in HCC treated with transcatheter arterial embolization. Usefulness of laminin staining as a post-surgical detection procedure at the tumor invasion boundary.
Higuchi T; Kikuchi M
Int Surg; 1995; 80(2):115-9. PubMed ID: 8530224
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
[TBL] [Abstract][Full Text] [Related]
6. Distribution of albumin- and/or alpha-fetoprotein-positive cells in hepatocellular carcinoma.
Kojiro M; Kawano Y; Isomura T; Nakashima T
Lab Invest; 1981 Mar; 44(3):221-6. PubMed ID: 6162058
[TBL] [Abstract][Full Text] [Related]
7. Natural history of hepatocellular carcinoma as viewed by the pathologist.
Callea F
Appl Pathol; 1988; 6(2):105-16. PubMed ID: 2839213
[TBL] [Abstract][Full Text] [Related]
8. Pathology of early hepatocellular carcinoma: progression from early to advanced.
Kojiro M; Yano H; Nakashima O
Semin Surg Oncol; 1996; 12(3):197-203. PubMed ID: 8727611
[TBL] [Abstract][Full Text] [Related]
9. Serum alpha-1-antitrypsin and alpha-1-antichymotrypsin after surgical treatment and during postoperative clinical course of human gastric cancer.
Bernacka K; Kuryliszyn-Moskal A; Klimiuk PA
Neoplasma; 1993; 40(2):111-6. PubMed ID: 7688868
[TBL] [Abstract][Full Text] [Related]
10. An immunocytochemical study of the distribution of lysozyme, a1-antitrypsin and a1-antichymotrypsin in the normal and pathological gall bladder.
Aroni K; Kittas C; Papadimitriou CS; Papacharalampous NX
Virchows Arch A Pathol Anat Histopathol; 1984; 403(3):281-9. PubMed ID: 6428042
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
Herrmann G
Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma.
Cantaboni A; Sironi M; Taccagni GL; Ferrari AM
Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060
[TBL] [Abstract][Full Text] [Related]
14. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
15. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
16. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
Mun KS; Cheah PL; Baharudin NB; Looi LM
Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
[TBL] [Abstract][Full Text] [Related]
18. Integrins as differential cell lineage markers of primary liver tumors.
Volpes R; van den Oord JJ; Desmet VJ
Am J Pathol; 1993 May; 142(5):1483-92. PubMed ID: 7684197
[TBL] [Abstract][Full Text] [Related]
19. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma.
Kalogeraki A; Garbagnati F; Santinami M; Zoras O
Cancer; 2002 Oct; 96(5):301-5. PubMed ID: 12378598
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of poorly differentiated hepatocellular carcinoma.
Oishi K; Itamoto T; Amano H; Fukuda S; Ohdan H; Tashiro H; Shimamoto F; Asahara T
J Surg Oncol; 2007 Mar; 95(4):311-6. PubMed ID: 17326126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
